Journals / Annals of Medical Research / 2018 / Cilt: 25 - Sayı: 2

Autopsy in sudden cardiac deaths

Pages
299–304
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In our country molecular autopsy is only considered in rare and selected cases, but if these genetical evaluations were made more applicable and accessible via interdepartmental agreements and the application of new genetical diagnosis methods, it would be possible to develop standardized methods for the case selection of molecular autopsies in the future.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Sudden cardiac death is described as death that occur within the 1st hour of the onset of the symptoms or death within the 24 hours of the onset of symptoms in unwitnessesed deaths.
📊
Key Findings & Data:Studies conducted in our country reveal that cardiovascular origined deaths are the most frequent, with a rate of 20% of all deaths.
💡
Conclusion & Impact:In our country molecular autopsy is only considered in rare and selected cases, but if these genetical evaluations were made more applicable and accessible via interdepartmental agreements and the application of new genetical diagnosis methods, it would be possible to develop standardized methods for the case selection of molecular autopsies in the future.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Sudden cardiac death is described as death that occur within the 1st hour of the onset of the symptoms or death within the 24 hours of the onset of symptoms in unwitnessesed deaths. Studies conducted in our country reveal that cardiovascular origined deaths are the most frequent, with a rate of 20% of all deaths. Although sudden deaths in young people are rare, it is important to perform a detailed autopsy and other required procedures. The etiology of the sudden death is hard to determine for the forensic doctors and in 5-1% of all cases no certain cause is determined despite the macroscopic, toxicologic and histopathologic evaluations. European Society of Cardiovascular Pathology also recommends performing molecular autopsy when the certain cardiac cause cannot be determined morphological. This review aims to offer genetical consulting to the family members of the sudden cardiac death cases and clarify the etiology of death via genetical evaluation if the macroscopic, toxicologic and histopathologic examinations fail to explain thecause of the sudden cardiac death especially in children and young adults. The most important problems in our country are the lack of multidisiplinary approach and standardized management methods. In our country molecular autopsy is only considered in rare and selected cases, but if these genetical evaluations were made more applicable and accessible via interdepartmental agreements and the application of new genetical diagnosis methods, it would be possible to develop standardized methods for the case selection of molecular autopsies in the future.

🔖

Cite This Article

YENER, Z., CELBİS, O. (2022). Autopsy in sudden cardiac deaths. Annals of Medical Research, Cilt: 25 - Sayı: 2, 299–304. https://ajindex.com/articles/447260

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Fedakar R, Gok E, Cetin S, Baduroglu E, Saka NE, Aslanhan N. Medicolegal aspect of the young sudden cardiac deaths: A case report. Uludag Med J 2012;38(3):201-5.
  2. Cerrone M, Priori SG. Genetics of sudden death: focus on inherited channelopathies. Eur Heart J 2011;32(17):2109-18.
  3. Wilde AA, Behr ER. Genetic testing for inherited cardiac disease. Nat Rev Cardiol 2013;10(10):571-83.
  4. Wilhelm M, Bolliger SA, Bartsch C, Fokstuen S, Grant C, Martos V, et al. Sudden cardiac death in forensic medicine – Swiss recommendations for a multidisciplinary approach. Swiss Med Wkly 2015;145:14129. Semsarian C, Hamilton RM. Key role of the molecular autopsy in sudden unexpected death. Hearth Rhythm 2012;9(1):145-50.
  5. Deniz A, Demir M. 2015 Avrupa Kardiyoloji Derneği ventrikül aritmisi olan hastaların yönetimi ve ani kardiyak ölümün önlenmesi kılavuzu. Turk Kardiyol Dern Ars 2016;44(1):9-14.
  6. Madea B, Saukko P, Oliva A, Musshoff F. Molecular Pathology in Forensic Medicine-Introduction. Forensic Sci Int 2010;203(1–3):3-14.
  7. Hendrix A, Borleffs CJ, Vlink A, Doevendans PA, Wilde AA, van Langen IM, et al. Cardiogenetic screening of firstdegree relatives after sudden cardiac death in the young: a population-based approach. Europace 2011;13(5):716-22.
  8. Tester DJ, Ackerman MJ. Postmortem long QT syndrome genetic testing for sudden unexplained death in the young. J Am Coll Cardiol 2007;49(2):240-6.
  9. Choung HYG, Vyas M, Jocoby D, West B. Arrhythmogenic right ventricular cardiomyopathy (ARVC) in a young female athlete at 36 weeks gestation: a case report. Pathol Res Pract 2017;213(10):1302-5.
  10. Tester DJ, Medeiros-Domingo A, Will ML, Haglund CM, Ackerman MJ. Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing. Mayo Clin Proc 2012;87(6):524-34.
  11. Skinner JR, Crawford J, Smith W, Aitken A, Heaven D, Evans C, et al. Prospective, population-based long QT molecular autopsy study of postmortem negative sudden death in 1 to 40 year olds. Heart Rhythm 2011;8(3):412-9.
  12. Pilmer CM, Kirsh JA, Hildebrandt D, Krahn AD, Gow RM. Sudden cardiac death in children and adolescents between 1 and 19 years of age. Heart Rhythm 2014;11(2):239-45.
  13. Semsarian C, Ingles J, Wilde AA. Sudden cardiac death in the young: The molecular autopsy and a practical approach to surviving relatives. Eur Hear J 2015;36(21):1290–6.
  14. Leone O, Agostini V, Foà A, Cerbelli B, Rosaria C, Aromatario M, et al. Cardiac pathologic findings in thr